Literature DB >> 22219349

Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality.

Vicente F Corrales-Medina1, Daniel M Musher, George A Wells, Julio A Chirinos, Li Chen, Michael J Fine.   

Abstract

BACKGROUND: Community-acquired pneumonia (CAP) affects >5 million adults each year in the United States. Although incident cardiac complications occur in patients with community-acquired pneumonia, their incidence, timing, risk factors, and associations with short-term mortality are not well understood. METHODS AND
RESULTS: A total of 1343 inpatients and 944 outpatients with community-acquired pneumonia were followed up prospectively for 30 days after presentation. Incident cardiac complications (new or worsening heart failure, new or worsening arrhythmias, or myocardial infarction) were diagnosed in 358 inpatients (26.7%) and 20 outpatients (2.1%). Although most events (89.1% in inpatients, 75% in outpatients) were diagnosed within the first week, more than half of them were recognized in the first 24 hours. Factors associated with their diagnosis included older age (odds ratio [OR]=1.03; 95% confidence interval [CI], 1.02-1.04), nursing home residence (OR, 1.8; 95% CI, 1.2-2.9), history of heart failure (OR, 4.3; 95% CI, 3.0-6.3), prior cardiac arrhythmias (OR, 1.8; 95% CI, 1.2-2.7), previously diagnosed coronary artery disease (OR, 1.5; 95% CI, 1.04-2.0), arterial hypertension (OR, 1.5; 95% CI, 1.1-2.1), respiratory rate ≥30 breaths per minute (OR, 1.6; 95% CI, 1.1-2.3), blood pH <7.35 (OR, 3.2; 95% CI, 1.8-5.7), blood urea nitrogen ≥30 mg/dL (OR, 1.5; 95% CI, 1.1-2.2), serum sodium <130 mmol/L (OR, 1.8; 95% CI, 1.02-3.1), hematocrit <30% (OR, 2.0; 95% CI, 1.3-3.2), pleural effusion on presenting chest x-ray (OR, 1.6; 95% CI, 1.1-2.4), and inpatient care (OR, 4.8; 95% CI, 2.8-8.3). Incident cardiac complications were associated with increased risk of death at 30 days after adjustment for baseline Pneumonia Severity Index score (OR, 1.6; 95% CI, 1.04-2.5).
CONCLUSIONS: Incident cardiac complications are common in patients with community-acquired pneumonia and are associated with increased short-term mortality. Older age, nursing home residence, preexisting cardiovascular disease, and pneumonia severity are associated with their occurrence. Further studies are required to test risk stratification and prevention and treatment strategies for cardiac complications in this population.

Entities:  

Mesh:

Year:  2012        PMID: 22219349     DOI: 10.1161/CIRCULATIONAHA.111.040766

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  117 in total

1.  A Hypothesis-Generating Study of the Combination of Aspirin plus Macrolides in Patients with Severe Community-Acquired Pneumonia.

Authors:  Marco Falcone; Alessandro Russo; Yuichiro Shindo; Alessio Farcomeni; Filippo Pieralli; Roberto Cangemi; Jinliang Liu; Jingyan Xia; Junya Okumura; Masahiro Sano; Christopher Jones; Vieri Vannucchi; Massimo Mancone; Scott Micek; Feng Xu; Francesco Violi; Marin Kollef
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

2.  Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling.

Authors:  Luis F Reyes; Marcos I Restrepo; Cecilia A Hinojosa; Nilam J Soni; Antonio Anzueto; Bettina L Babu; Norberto Gonzalez-Juarbe; Alejandro H Rodriguez; Alejandro Jimenez; James D Chalmers; Stefano Aliberti; Oriol Sibila; Vicki T Winter; Jacqueline J Coalson; Luis D Giavedoni; Charles S Dela Cruz; Grant W Waterer; Martin Witzenrath; Norbert Suttorp; Peter H Dube; Carlos J Orihuela
Journal:  Am J Respir Crit Care Med       Date:  2017-09-01       Impact factor: 21.405

3.  Influenza-induced thrombocytopenia is dependent on the subtype and sialoglycan receptor and increases with virus pathogenicity.

Authors:  A J Gerard Jansen; Thom Spaan; Hui Zhi Low; Daniele Di Iorio; Judith van den Brand; Malte Tieke; Arjan Barendrecht; Kerstin Rohn; Geert van Amerongen; Koert Stittelaar; Wolfgang Baumgärtner; Albert Osterhaus; Thijs Kuiken; Geert-Jan Boons; Jurriaan Huskens; Marianne Boes; Coen Maas; Erhard van der Vries
Journal:  Blood Adv       Date:  2020-07-14

4.  Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling.

Authors:  Armand O Brown; Carlos J Orihuela
Journal:  J Vis Exp       Date:  2015-04-07       Impact factor: 1.355

Review 5.  Crosstalk Between Lung and Extrapulmonary Organs in Infection and Inflammation.

Authors:  Zhihan Wang; Qinqin Pu; Canhua Huang; Min Wu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  No effect of fitness on brachial or forearm vascular function during acute inflammation in young adults.

Authors:  Elizabeth C Schroeder; Thessa I M Hilgenkamp; Wesley K Lefferts; Nadia Robinson; Tracy Baynard; Bo Fernhall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-09-25       Impact factor: 3.619

7.  Is NOX2 upregulation implicated in myocardial injury in patients with pneumonia?

Authors:  Roberto Cangemi; Camilla Calvieri; Tommaso Bucci; Roberto Carnevale; Marco Casciaro; Elisabetta Rossi; Cinzia Myriam Calabrese; Gloria Taliani; Stefania Grieco; Marco Falcone; Paolo Palange; Giuliano Bertazzoni; Andrea Celestini; Pasquale Pignatelli; Francesco Violi
Journal:  Antioxid Redox Signal       Date:  2014-03-14       Impact factor: 8.401

Review 8.  Long-term prognosis in community-acquired pneumonia.

Authors:  Marcos I Restrepo; Paola Faverio; Antonio Anzueto
Journal:  Curr Opin Infect Dis       Date:  2013-04       Impact factor: 4.915

9.  Pneumolysin Mediates Platelet Activation In Vitro.

Authors:  Jan Gert Nel; Chrisna Durandt; Timothy J Mitchell; Charles Feldman; Ronald Anderson; Gregory R Tintinger
Journal:  Lung       Date:  2016-05-18       Impact factor: 2.584

10.  Longitudinal Study of the Effects of Bacteremia and Sepsis on 5-year Risk of Cardiovascular Events.

Authors:  S Reza Jafarzadeh; Benjamin S Thomas; David K Warren; Jeff Gill; Victoria J Fraser
Journal:  Clin Infect Dis       Date:  2016-05-18       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.